Panacea Biotec debuts EasyFourPol fully-liquid wP-IPV pentavalent vaccine in India
Panacea Biotec, one of India's leading biotechnology companies, is proud to announce two major developments: the launch of the world's first fully-liquid wP-IPV based Pentavalent ... Read More
Panacea Biotec gets $127.3m worth orders for Easyfive-TT from UNICEF, PAHO
Panacea Biotec, an Indian biotechnology company, has been awarded supply orders worth $127.3 million from United Nations Children's Fund (UNICEF) and Pan American Health Organization ... Read More
Panacea Biotec sells domestic formulations brands to Mankind Pharma
Panacea Biotec said that its fully-owned subsidiary Biotec Pharma Ltd. (PBPL) has agreed to sell its domestic formulations brands for India and Nepal to Mankind ... Read More
Panacea Biotec supplies first shipment of Sputnik V second component produced in India
Panacea Biotec and the Russian Direct Investment Fund (RDIF) said that the former has supplied the first shipment of the second component of the Russian ... Read More
Panacea Biotech to produce 25 million doses of Sputnik V corona vaccine
Indian vaccine producer Panacea Biotech has signed a licensing deal for producing 25 million doses of the Sputnik V corona vaccine. The company has entered ... Read More
Panacea Biotec gets manufacturing license for Sputnik V vaccine
Panacea Biotec has secured a manufacturing license from the Drugs Controller General of India (DCGI) for Sputnik V vaccine against Covid-19 following its collaboration with ... Read More
Panacea Biotec begins production of Sputnik V Covid vaccine in India
Russia’s sovereign wealth fund - Russian Direct Investment Fund (RDIF) and Indian vaccine and pharma manufacturer Panacea Biotec have launched production of the Sputnik V ... Read More